Yulia Jitkova

2.9k total citations
21 papers, 386 citations indexed

About

Yulia Jitkova is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yulia Jitkova has authored 21 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Hematology and 4 papers in Oncology. Recurrent topics in Yulia Jitkova's work include Acute Myeloid Leukemia Research (8 papers), Mitochondrial Function and Pathology (6 papers) and Histone Deacetylase Inhibitors Research (6 papers). Yulia Jitkova is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Mitochondrial Function and Pathology (6 papers) and Histone Deacetylase Inhibitors Research (6 papers). Yulia Jitkova collaborates with scholars based in Canada, United States and United Kingdom. Yulia Jitkova's co-authors include Aaron D. Schimmer, Marcela Gronda, Rose Hurren, Mark D. Minden, Neil MacLean, Mahadeo A. Sukhai, Joseph Brandwein, Vikas Gupta, Karen Yee and Bozhena Jhas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Yulia Jitkova

17 papers receiving 381 citations

Peers

Yulia Jitkova

HEMAT

ONCOL

IMMUN

Brandon Carter‐Cooper United States

Kwang-Sung Ahn South Korea

Tingbo Liu China

Yoko Inaguma Japan

Akinao Okamoto Japan

Kazutaka Takagi Japan

Maria Dan United States

Marie A. Hollenhorst United States

Brandon Carter‐Cooper United States

Yulia Jitkova

222 ×1.0

104 ×0.9

HEMAT

70 ×0.7

ONCOL

65 ×0.9

28 ×0.5

IMMUN

Citations per year, relative to Yulia Jitkova Yulia Jitkova (= 1×) peers Brandon Carter‐Cooper

Countries citing papers authored by Yulia Jitkova

Since Specialization

Citations

This map shows the geographic impact of Yulia Jitkova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulia Jitkova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulia Jitkova more than expected).

Fields of papers citing papers by Yulia Jitkova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulia Jitkova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulia Jitkova. The network helps show where Yulia Jitkova may publish in the future.

Co-authorship network of co-authors of Yulia Jitkova

This figure shows the co-authorship network connecting the top 25 collaborators of Yulia Jitkova. A scholar is included among the top collaborators of Yulia Jitkova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulia Jitkova. Yulia Jitkova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jitkova, Yulia, Algirdas Vėlyvis, Robert W. Harkness, et al.. (2025). Mechanism of allosteric activation in human mitochondrial ClpP protease. Proceedings of the National Academy of Sciences. 122(16). e2419881122–e2419881122. 3 indexed citations

Voisin, Véronique, Marcela Gronda, Lan-Xin Zhang, et al.. (2025). Abstract 3033: Increased mitochondrial protein import necessitates greater reliance on the mitochondrial unfolded protein response (UPRmt) and the protease LONP1 to maintain mitochondrial protein solubility and cell viability in acute myeloid leukemia (AML). Cancer Research. 85(8_Supplement_1). 3033–3033.

Feng, Yue, Yulia Jitkova, Jonathan St‐Germain, et al.. (2024). Abstract 7053: Serine phosphorylation marks proteins for degradation by the mitochondrial matrix protease, ClpXP. Cancer Research. 84(6_Supplement). 7053–7053.

Dimitriou, Ioannis D., David Meiri, Yulia Jitkova, et al.. (2022). Translational Control by 4E-BP1/2 Suppressor Proteins Regulates Mitochondrial Biosynthesis and Function during CD8+ T Cell Proliferation. The Journal of Immunology. 208(12). 2702–2712.

Lee, Jong Bok, Dilshad H. Khan, Rose Hurren, et al.. (2021). Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production. Blood. 138(3). 234–245. 103 indexed citations

Prabhu, Varun V., Sara Morrow, Abed Rahman Kawakibi, et al.. (2020). EXTH-74. IND-ENABLING CHARACTERIZATION OF DUAL DRD2- AND ClpP-TARGETING AGENT ONC206 AS THE NEXT IMIPRIDONE FOR CLINICAL NEURO-ONCOLOGY. Neuro-Oncology. 22(Supplement_2). ii103–ii103. 2 indexed citations

Grouleff, Julie, Yulia Jitkova, Diego B. Diaz, et al.. (2019). De Novo Design of Boron-Based Peptidomimetics as Potent Inhibitors of Human ClpP in the Presence of Human ClpX. Journal of Medicinal Chemistry. 62(13). 6377–6390. 41 indexed citations

Xu, Mingjing, Val A. Fajardo, Geethu Emily Thomas, et al.. (2019). Abstract 3003: Inhibiting the mitochondrial enzyme phosphatidylserine decarboxylase (PISD) reduces stemness and increases differentiation in acute myeloid leukemia (AML). 3003–3003.

Hurren, Rose, Mark R. Albertella, Marcela Gronda, et al.. (2018). The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia. Haematologica. 104(5). 963–972. 17 indexed citations

10.

Singh, Rashim Pal, Danny V. Jeyaraju, Véronique Voisin, et al.. (2018). Targeting the Mitochondrial Metallochaperone Cox17 Reduces DNA Methylation and Promotes AML Differentiation through a Copper Dependent Mechanism. Blood. 132(Supplement 1). 1339–1339. 4 indexed citations

11.

Jeyaraju, Danny V., Véronique Voisin, Changjiang Xu, et al.. (2017). Inhibiting the Mitochondrial Sulfhydryl Oxidase Alr Reduces Cox17 and Alters Mitochondrial Cristae Structure Leading to the Differentiation of AML and Stem Cells. Blood. 130(Suppl_1). 881–881. 1 indexed citations

12.

Jeyaraju, Danny V., Véronique Voisin, Changjiang Xu, et al.. (2016). Inhibition of the Mitochondrial Protein Import Machinery Is Selectively Cytotoxic to Acute Myeloid Leukemia (AML) Cells and Stem Cells. Blood. 128(22). 1572–1572. 1 indexed citations

13.

Reed, Gregory A., Gary J. Schiller, Suman Kambhampati, et al.. (2016). A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia. Cancer Medicine. 5(11). 3031–3040. 63 indexed citations

14.

Wu, Yan, Rose Hurren, Neil MacLean, et al.. (2015). Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells. APOPTOSIS. 20(8). 1099–1108. 40 indexed citations

15.

Yip, Kenneth W., Zhan Zhang, Jui-Wen Huang, et al.. (2014). A Porphodimethene Chemical Inhibitor of Uroporphyrinogen Decarboxylase. PLoS ONE. 9(2). e89889–e89889. 3 indexed citations

16.

Jitkova, Yulia, Marcela Gronda, Rose Hurren, et al.. (2014). A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity. PLoS ONE. 9(5). e95281–e95281. 33 indexed citations

17.

Jhas, Bozhena, Shrivani Sriskanthadevan, Marko Škrtić, et al.. (2013). Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells. PLoS ONE. 8(3). e58367–e58367. 30 indexed citations

18.

Schimmer, Aaron D., Yulia Jitkova, Marcela Gronda, et al.. (2012). A Phase I Study of the Metal Ionophore Clioquinol in Patients With Advanced Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 12(5). 330–336. 34 indexed citations

19.

Minden, Mark D., Donna E. Hogge, Scott J. Weir, et al.. (2012). Clinical Proof of Concept Trial of Oral Ciclopirox Olamine in Patients with Relapsed/Refractory Hematologic Malignancy. Blood. 120(21). 1372–1372. 5 indexed citations

20.

Kogan, Alexander E, et al.. (1993). Reduced procoagulant, coagulation factor splitting and antiaggregatory activity of acylated plasminoqen-streptoki-nase (Pg-SK) activator complex. Thrombosis and Haemostasis. 69(6). 843. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact